InvestorsHub Logo
Followers 32
Posts 6922
Boards Moderated 0
Alias Born 12/07/2003

Re: Joda post# 3654

Friday, 05/29/2015 1:56:00 PM

Friday, May 29, 2015 1:56:00 PM

Post# of 7724
Oh sorry, forgot to say...

Incyte is pretty close to Geron in structure.

Their main drug is the one Geron is about to prove it is superior than...

Incyte
Incyte Corporation (INCY) -NasdaqGS
110.71 Up 2.57

Shares Outstanding5: 179.04M
Float: 162.41M


One might want to consider shorting Incyte, and going Long Geron.

One might also consider how much money will be lost or gained by some people, depending on the success of Geron being able to help cure some people.

There is an extremely ugly side to bio's and pharma, when profits can be focused more than patients...

Hence a lot of the Message Board assaults (yahoo, SI), lawsuits and press releases (adam) against Geron...

"evil flourishes when good people fail to act"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GERN News